Figure 1.
Diagram of the TATI project with the number of visual examinations performed by midwives in the pilot phase (months-3–0), during the time of the comparative study (months 1–11) and after the comparative study (months 12–33).
VIA = Visual inspection after the application of acetic acid. C-TATI = Comparative screening study (months 1–11). R-TATI = rest of the TATI intervention (months 1–33).
Figure 2.
Box plots of positivity rates of VIA, HPV, LBC and Pap and of inadequate rates of LBC and Pap in C-TATI.
VIA = Visual inspection after the application of acetic acid. HPV = Human papillomavirus. LBC = Liquid-based cytology. C-TATI = Comparative screening study (months 1–11). D = Dispersion factor. ASCUS+ = Atypical squamous changes of undetermined significance or worse cytological abnormalities. Inad = Inadequate.
Table 1.
Variation of VIA positivity rates per midwife over the 33 months of the TATI intervention by group of midwives.
Table 2.
Variation of VIA positivity rates per midwife by group of midwives and year of intervention within R-TATI.
Figure 3.
Funnel plots of the variation of positivity rates of VIA performed by midwives over 33 months of the TATI intervention.
C- TATI = Comparative screening study (months 1–11). R-TATI = rest of the TATI intervention (months 1–33). Group 1: 19 midwives who participated in C-TATI and R-TATI. Group 2: 23 midwives who did not participate in C-TATI. Positivity rates of VIA performed by midwives in Group 1 are represented by capital letters “A” to “S”. Positivity rates of VIA performed by midwives in Group 2 are represented by small letters “a” to “w”.
Figure 4.
Proportion of VIA exams reported positive according to the number of VIA exams carried out by midwives who performed 500 or more VIA exams throughout the intervention.
Proportion of VIA exams reported positive by midwives in Group 1 are represented by capital letters and those of midwives in Group 2 by small letters.